Topic: vaccine development
Serum Institute of India plans to launch four vaccines in the coming years for pneumococcal, HPV, meningococcal and dengue.
A Sanofi exec defended its dengue shot in the Philippines on Monday as new reports showed local experts had warned against a broad vaccination push.
Already reeling from bad news on its dengue shot, Sanofi canned its phase 3 C. diff vaccine—and the $500 million-plus in sales that might have come with it.
With financial support from BARDA, Takeda's purified, inactivated, alum-adjuvanted Zika vaccine has entered human testing.
Before heading offshore for a dubious herpes vaccine trial, a Southern Illinois University did such experiments on people in the U.S.
Despite a frantic effort to rush Ebola vaccines through testing during an epidemic, Merck will fall short in its goal to file its candidate this year.
Immunovaccine and Leidos are working together to determine the most promising malaria vaccine formulations.
Now that Prostvac has failed as a stand-alone therapy, Bavarian Nordic's MVA-BN RSV vaccine is now extra-important.
Takeda's dengue vaccine induced sustained antibody responses in children, topline phase 2 data showed.
Sanofi Pasteur has tapped Berg to learn more about biomarkers behind flu vaccine responses.